Clinical Trial Update: Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A pediatric Phase 1/2 trial evaluating nivolumab in combination with metronomic chemotherapy for refractory/relapsing solid tumors; the study status is ACTIVE_N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Metronomic chemotherapy (metronomic chemotherapy)
• nivolumab (nivolumab)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Childhood Solid Tumor | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING